An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer

Sponsor
Saint John's Cancer Institute (Other)
Overall Status
Completed
CT.gov ID
NCT03069105
Collaborator
(none)
49
4
38.1
12.3
0.3

Study Details

Study Description

Brief Summary

This study will look at caregiver burden and the coping behavior of caregivers of patients with cancer. Through this study, the investigators will identify the relationship between cognitive dysfunction (measured as a proxy rating by the caregiver), resilience, social support, cognitive appraisal, coping behavior, and caregiver burden, anxiety, and depression among family caregivers of patients with cancer.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire

Detailed Description

The goal of this study is to explore caregiver burden and the coping behavior of caregivers of patients with cancer. It has been documented that non-professional caregivers and long-term care providers to patients with cancer receive little preparation, information, or support to perform their vital role. Through this study, the investigators will identify the relationship between cognitive dysfunction, resilience, social support, cognitive appraisal, coping behavior, and caregiver burden, anxiety, and depression among family caregivers of patients with cancer. The findings of this study will direct future intervention studies to reduce caregiver burden and improve outcomes for the many individuals caring for family members with cancer.

Study Design

Study Type:
Observational
Actual Enrollment :
49 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
An Exploratory Study of Caregiver Burden Among Family Caregivers of Cancer Patients
Actual Study Start Date :
Feb 23, 2017
Actual Primary Completion Date :
Apr 28, 2020
Actual Study Completion Date :
Apr 28, 2020

Arms and Interventions

Arm Intervention/Treatment
Family caregivers

The sample for this study will consist of caregivers of patients with cancer. Eligible subjects who agrees to participate in the research study and sign the consent form will participate by completing paper and pencil or electronic questionnaires.

Other: Questionnaire
Participants will complete paper and pencil or electronic questionnaires at the cancer center or in the privacy of their own homes.

Outcome Measures

Primary Outcome Measures

  1. Changes in Caregiver Burden Score [Caregiver Reaction Assessment (CRA)] [1 year]

    Relation between caregiver burden subscale scores and caregiver resilience, social support, and coping

Secondary Outcome Measures

  1. Changes in Anxiety and Depression Score [Hospital Anxiety and Depression Scale (HADS)] [1 year]

    Relation between caregiver anxiety and depression score and caregiver resilience, social support, and coping

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age ≥ 18 years

  • Self-identified primary caregiver of patients with cancer

  • Co-residence with the patient

  • Providing a minimum of 4 hours of direct care for at least 3 days per week

  • Able to speak, read, and understand English

  • Willing to participate in completion of surveys

Exclusion Criteria:
  • Professional or paid caregivers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Providence Saint Joseph Medical Center Burbank California United States 91505
2 Providence Holy Cross Medical Center Mission Hills California United States 91345
3 John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica California United States 90404
4 EndBrainCancer Initiative/Chris Elliott Fund Redmond Washington United States 98052

Sponsors and Collaborators

  • Saint John's Cancer Institute

Investigators

  • Study Chair: Santosh Kesari, MD PhD, Saint John's Cancer Institute
  • Principal Investigator: Marlon G Saria, PhD RN FAAN, John Wayne Cancer Institute at Providence Saint John's Health Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Marlon Garzo Saria, Assistant Professor, Saint John's Cancer Institute
ClinicalTrials.gov Identifier:
NCT03069105
Other Study ID Numbers:
  • JWCI-16-1201
First Posted:
Mar 3, 2017
Last Update Posted:
Nov 13, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 13, 2020